title: Intermittent hypoxia and activation of inflammatory molecular pathways in OSAS.
abstract: Obstructive sleep apnoea syndrome (OSAS) represents a highly prevalent disease and is recognized as a risk factor for the development of various cardiovascular disorders. The pathogenesis of cardiovascular complications in OSAS is not completely understood, but the unique form of hypoxia with repetitive short cycles of desaturation followed by rapid reoxygenation termed intermittent hypoxia (IH) is likely to play a significant role. There is increasing evidence that IH leads to a preferential activation of inflammatory over adaptive pathways. This promotes activation of various inflammatory cells, particularly lymphocytes and monocytes, with the downstream consequence of expression of pro-inflammatory cytokines, chemokines and adhesion molecules that may contribute to endothelial dysfunction. This review provides a critical analysis of the current evidence of inflammatory mechanisms initiated by IH that may contribute to the cardiovascular pathogenesis in OSAS.
authors.affiliation: Sleep Research Laboratory, St. Vincent's University Hospital, Dublin, Ireland.
authors.forename: Silke
authors.initials: S
authors.lastname: Ryan
authors.forename: Walter T
authors.initials: WT
authors.lastname: McNicholas
mesh_terms: D000818:Animals; D002318:Cardiovascular Diseases / Q000378:metabolism / Q000473:pathology*; D002448:Cell Adhesion; D016207:Cytokines / Q000378:metabolism; D006801:Humans; D000860:Hypoxia; D007249:Inflammation / Q000473:pathology*; D008214:Lymphocytes / Q000378:metabolism; D008954:Models, Biological; D009000:Monocytes / Q000378:metabolism; D009765:Obesity / Q000150:complications; D020181:Sleep Apnea, Obstructive / Q000150:complications / Q000378:metabolism* / Q000503:physiopathology*
chemical_list: D016207:Cytokines